Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

COLL Company Profile and Key Details

NASDAQ : COLL

Collegium Pharmaceutical, Inc.

$27.21
-0.39-1.41%
Open: 10:59 AM
51.46
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Collegium Pharmaceutical, Inc. (COLL) stock declined over -1.41%, trading at $27.21 on NASDAQ, down from the previous close of $27.60. The stock opened at $27.51, fluctuating between $27.13 and $27.57 in the recent session.

Stock Snapshot

27.6
Prev. Close
874.31M
Market Cap
27.1301
Day Low
14.63
P/E Ratio
1.86
EPS (TTM)
8.49
Cash Flow per Share
27.51
Open
32.13M
Number of Shares
27.57
Day High
95.68%
Free Float in %
6.05
Book Value
22.62K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 29, 202526.7827.7026.6827.60250.98K
Apr 28, 202526.9827.3526.6726.87158.64K
Apr 25, 202526.6027.0926.2226.79214.65K
Apr 24, 202526.0726.9425.9826.78288.8K
Apr 23, 202527.2027.4825.8725.99375.31K
Apr 22, 202527.2427.9326.8326.89435.35K
Apr 21, 202526.8627.6126.4826.91351.67K
Apr 17, 202527.0027.7826.8927.01227.92K
Apr 16, 202527.1927.5426.6627.02282.98K
Apr 15, 202526.6427.5726.6427.12358.92K
Apr 14, 202526.7327.1926.2526.73616.83K
Apr 11, 202524.9826.3424.4726.30612.22K
Apr 10, 202525.9925.9923.2324.67560.8K
Apr 09, 202524.7926.8224.3426.37578.69K
Apr 08, 202528.0028.0025.1725.41666.26K
Apr 07, 202527.4128.3726.6427.38484.86K
Apr 04, 202528.1528.3427.6728.14384.61K
Apr 03, 202529.5529.7628.8729.02280.89K
Apr 02, 202529.1930.0229.1230.00216.38K
Apr 01, 202529.8530.5329.0129.39427.89K

Contact Details

Stoughton, MA 02072

United States

https://www.collegiumpharma.com781 713 3699

About Company

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Company Information

Employees357
Beta0.76
Sales or Revenue$566.77M
5Y Sales Change%0.97%
Fiscal Year EndsDecember
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current Collegium Pharmaceutical, Inc. (COLL) stock price?
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stock price is $27.21 in the last trading session. During the trading session, COLL stock reached the peak price of $27.57 while $27.13 was the lowest point it dropped to. The percentage change in COLL stock occurred in the recent session was -1.41% while the dollar amount for the price change in COLL stock was -$0.39.
COLL's industry and sector of operation?
The NASDAQ listed COLL is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Collegium Pharmaceutical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of COLL?
Mr. Bart J. Dunn
Executive Vice President of Strategy & Corporation Devel.
Mr. Scott Sudduth
Head of Technical Operations
Ms. Marlo Manning
Head of HR
Ms. Shirley R. Kuhlmann
Executive Vice President, Gen. Counsel, Chief Admin. Officer & Sec.
Ms. Alex Dasalla
Head of Investor Relations
Dr. Richard Malamut M.D.
Executive Vice President & Chief Medical Officer
Dr. Thomas B. Smith FAAFP, M.D.
Executive Vice President & Chief Medical Officer
Mr. Joseph J. Ciaffoni
Pres, Chief Executive Officer & Director
Ms. Colleen Tupper
Executive Vice President & Chief Financial Officer
Mr. Scott Dreyer
Executive Vice President & Chief Commercial Officer
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
Co-Founder & Chairman
How COLL did perform over past 52-week?
COLL's closing price is 18.81% higher than its 52-week low of $23.23 where as its distance from 52-week high of $42.29 is -34.73%.
How many employees does COLL have?
Number of COLL employees currently stands at 357.
Link for COLL official website?
Official Website of COLL is: https://www.collegiumpharma.com
How do I contact COLL?
COLL could be contacted at phone 781 713 3699 and can also be accessed through its website. COLL operates from 100 Technology Center Drive, Stoughton, MA 02072, United States.
How many shares of COLL are traded daily?
COLL stock volume for the day was 22.62K shares. The average number of COLL shares traded daily for last 3 months was 398.87K.
What is the market cap of COLL currently?
The market value of COLL currently stands at $874.31M with its latest stock price at $27.21 and 32.13M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph